🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06119321
Active, not recruiting Observational

A Study of a Novel Scheimpflug Device in Diagnosing Keratoconus

NCT06119321 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Eye Hospital
Phase
Observational
Started
2023-05-04
Last updated
2024-11-04

Condition(s) studied

ScansysPentacamCorvis STKeratoconusSubclinical Keratoconus

Investigational drug(s) / intervention(s)

Pentacam, Corvis ST and Scansys

Pentacam, Corvis ST and Scansys: morphological and biomechanical parameters of corneal were obtain by Scansys, Pentacam and Corvis ST

Study summary

Comparison of the screening and diagnosis ability of the novel Scheimpflug-based tomography device (Scansys) with Pentacam and the Scheimpflug-based biomechanics device (Corvis ST) for keratoconus.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
Accepted
Inclusion criteria: * Best corrected visual acuity (BCVA) ≥ 20/20; * No other eye diseases except myopia and astigmatism; * The cornea was transparent, and there was no cloud or pannus; Exclusion Criteria: * The presence of ocular diseases other than myopia and keratoconus; * Ocular trauma; * Previous ocular surgery; * Patients were required to stop wearing soft contact lenses for at least 2 weeks and rigid contact lenses for at least 4 weeks before examination; * Pregnant and lactating women;

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tiajin Eye Hospital Tianjin Tianjin Municipality

More Tianjin Eye Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06119321 on ClinicalTrials.gov ↗ ← All trials in China